COMMUNIQUÉS West-GlobeNewswire

BrainStorm Announces Grant of an additional New European Patent for NurOwn®
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the European [...]
CampDoc and Waldo Photos Announce New Partnership for Facial Recognition Photo Sharing with Parents
26/03/2019
ANN ARBOR, Mich., March 26, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps , is excited to announce a new partnership with Waldo Photos , an Austin-based startup that uses facial [...]
Bhang Corporation’s Scott Van Rixel and Jamie Pearson Named to High Times' Most Influential People in Cannabis
26/03/2019
LOS ANGELES, March 26, 2019 (GLOBE NEWSWIRE) -- Bhang Corporation ("Bhang" or the "Company"), the global cannabis house of brands with an extensive, award-winning portfolio of products, is proud to announce that Bhang [...]
American Addiction Centers: Fentanyl Presence Rising in Client Testing
26/03/2019
Testing Data and Monitoring of DEA Seizure Reports Reveals Need to Expand and Refine Screening Criteria to Detect Dangerous Street Drugs that Impact Intake, Care BRENTWOOD, Tenn., March 26, 2019 (GLOBE NEWSWIRE) -- With [...]
Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day
26/03/2019
Program and webcast – today, March 26, 2019 at 8:00 am ET LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next generation [...]
Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares
26/03/2019
ANN ARBOR, Mich., March 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced [...]
LIDDS: NanoZolid® technology receives US patent valid until 2037
26/03/2019
The United States Patent and Trademark Office has issued a Notice of Allowance for the NanoZolid ® technology patent. This will provide additional patent protection for all LIDDS development projects. The same patent [...]
Notice of Annual General Meeting in Immunicum AB (publ)
26/03/2019
Press Release 26 March 2019 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to the Annual General Meeting on [...]
Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) en vedette dans la publication NetworkNewsWire sur l'industrie du CBD à base de chanvre en forte progression
26/03/2019
NEW YORK, 26 mars 2019 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (« NNW »), société d’information financière et d’édition à multiples facettes, annonce aujourd’hui la publication d’un éditorial présentant [...]
CFO of Oasmia, Anders Blom has resigned
26/03/2019
Yesterday Oasmia received the resignation of the Company’s CFO Anders Blom. The Board and the CEO have decided to appoint, as acting CFO, Joakim Lindén. Joakim Lindén has long experience from transition processes in [...]
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
26/03/2019
Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero Platform across Europe [...]
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
26/03/2019
LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
26/03/2019
Moving forward with Overall Survival (OS)-based, randomized, event-driven clinical trial for the United States Pre-IND feedback from US Food and Drug Administration (FDA) provides clarity to Nanobiotix on US regulatory [...]
Nanobiotix annonce son plan d’enregistrement clinique dans les cancers de la Tête et du Cou avec NBTXR3 aux Etats-Unis à la suite du retour de la FDA
26/03/2019
Préparation d’une étude clinique évènementielle, randomisée et évaluant la survie globale (SG) aux États-Unis Le retour (pre-IND) de la Food and Drug Administration (FDA) permet de clarifier l’approche réglementaire aux [...]
Tecan publishes 2018 Annual Report and notice of its Annual General Meeting
26/03/2019
Männedorf, Switzerland, March 26, 2019 - The Tecan Group (SIX Swiss Exchange: TECN) today announced the publication of its 2018 Annual Report in the Investor Relations section of the company's website at www.tecan.com [...]
Multidisciplinary Experts Leverage Global Action for Local Impact to Protect Communities at Risk of Typhoid and Related Diseases
26/03/2019
HANOI, Vietnam, March 25, 2019 (GLOBE NEWSWIRE) -- Beginning today, the 11 th International Conference on Typhoid and Other Invasive Salmonelloses brings together more than 450 researchers, policy makers and advocates [...]
Novel compound for treatment of traumatic brain injury (TBI) demonstrates positive results in a preclinical study
25/03/2019
Strongest announced preclinical results of any drug candidate currently in development for TBI Significant results in neurobehavior as measured by actigraphy. GRAFTON, Mass., March 25, 2019 (GLOBE NEWSWIRE) -- Ischemix [...]
RadNet, Inc. to Present at the Sidoti & Company Spring 2019 Conference on Thursday, March 28th
25/03/2019
LOS ANGELES, March 25, 2019 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated [...]
Precision Therapeutics Announces Results of Special Meeting of Stockholders
25/03/2019
MINNEAPOLIS, March 25, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (Nasdaq: AIPT) (the “Company”) announced today that at a special meeting of stockholders held on March 22, 2019, the Company’s stockholders [...]

Pages